NCT05724030Completed
Use of Integrated Pulmonary Index Monitorisation in Children Undergoing Botulinum Toxin Injection
Effect of Integrated Pulmonary Index on Hypoxia
Source: ClinicalTrials.gov · Last updated 15 Oct 2024
Brief summary (registry, in English)
This study aimed to detect hypoxia early with ıntegrated pulmonary index monitoring compared to saturation.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 69 (actual)
- First submitted
- 24 Jan 2023
- Start date
- 3 Apr 2023
- Primary completion date
- 3 Sept 2024
- Lead sponsor
- Kocaeli University
- NCT number
- NCT05724030
What you commit to
- Study type: Interventional
- Participants enrolled: 69
- From 3 Apr 2023 to the primary completion date, 3 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- patients with upper respiratory tract infection
Age
- \> 18 age
Other
- asa 3-4
Who the study is looking for
- 4-16 age pediatrics
- undergoing botilinum injection with sedation
- asa 1-2
Age in the registry: 4 years to 16 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kocaeli University School of Medicine Coordinator of this site? Confirm its status | Kocaeli | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.